On the afternoon of September 11, in response to investors' questions about the company's business situation on the Shenzhen Stock Exchange Interactive Easy platform, Yimedicine said that at present, Nippon Machinery's CRRT business has been completed and is being integrated and cultivated according to the plan, and will take the opportunity to inject it into the listed company in the future.

On the afternoon of September 11, in response to investors' questions about the company's business situation on the Shenzhen Stock Exchange Interactive Easy platform, Yimedicine said that at present, Nippon Machinery's CRRT business has been completed and is being integrated and cultivated according to the plan, and will take the opportunity to inject it into the listed company in the future.